文献速递骨质疏松与代谢性骨病

FRAX在衰弱老年人中的表现:弗雷明汉心脏研究

Performance of FRAX in older adults with frailty: the Framingham Heart Study.
PubMed 文献 · Osteoporos Int · 2023-10-24

在弗雷明汉心脏研究的3554人中比较FRAX按衰弱状态的表现,10年随访期间衰弱者与无衰弱者的主要骨质疏松性骨折发生率分别为6.9%和3.0%。衰弱者中FRAX(不含BMD)的AUC为0.584,低于无衰弱者的0.695(P=0.02);衰弱者中FRAX包含BMD后AUC提高至0.658(P<0.01)。FRAX高估主要骨质疏松性骨折风险,无衰弱者高估更明显。

要点

  • 衰弱者10年主要骨质疏松性骨折发生率为6.9%,无衰弱者为3.0%。
  • 衰弱者FRAX(不含BMD)AUC 0.584,低于无衰弱者0.695(P=0.02)。
  • 衰弱者中FRAX包含BMD后AUC提高至0.658(P<0.01)。

核心结论

  • 与无衰弱者相比,FRAX可能较难识别有骨折风险的衰弱个体,除非有BMD信息可用。
  • 作者认为BMD捕捉了衰弱者骨折预测的重要特征。
  • 作者提出未来的骨折预测模型应在衰弱人群中开发。

研究设计与样本

  • 采用弗雷明汉心脏研究的队列研究,共纳入3554人。
  • 衰弱按Fried表型定义,主要骨质疏松性骨折从10年随访期间的病历中确认。
  • 通过逻辑回归模型计算AUC及观察与预测骨折概率评估FRAX的区分度和校准度,分析按衰弱状态分层。

主要发现

  • 衰弱者550/3554(15.5%),衰弱者较无衰弱者年龄更大(81.1岁 vs 67.6岁)、女性比例更高(68.6% vs 55.1%)、平均FRAX评分更高(主要骨质疏松性骨折:15.9% vs 10.1%)。
  • 随访期间衰弱者38人(6.9%)、无衰弱者91人(3.0%)发生主要骨质疏松性骨折。
  • FRAX(不含BMD)的AUC在衰弱者中为0.584(95%CI 0.504-0.663),低于无衰弱者的0.695(95%CI 0.649-0.741),P=0.02。
  • 衰弱者中FRAX包含BMD后AUC提高至0.658(P<0.01)。
  • FRAX高估主要骨质疏松性骨折风险,无衰弱者高估更明显;FRAX对髋部骨折的表现相似。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: We compared the performance of FRAX according to frailty status in 3554 individuals from the Framingham Study. During 10-year follow-up, 6.9% and 3.0% of participants with and without frailty experienced MOF. Discrimination profiles were lower in participants with frailty compared to those without, but they improved when FRAX included BMD. INTRODUCTION: Frailty increases fracture risk. FRAX was developed to predict fractures but never validated in individuals with frailty. We aimed to compare the predictive performance of FRAX (v4.3) in individuals with and without frailty. METHODS: We conducted a cohort study using the Framingham Heart Study. Frailty was defined by the Fried phenotype. Major osteoporotic fractures (MOF) were ascertained from medical records during 10-year follow-up. To evaluate discrimination and calibration of FRAX, we calculated the area-under-the-receiver-operating characteristics curves (AUC) using logistic regression models and observed-to-predicted fracture probabilities. Analyses were stratified by frailty status. RESULTS: Frailty was present in 550/3554 (15.5%) of participants. Participants with frailty were older (81.1 vs. 67.6 years), female (68.6% vs. 55.1%), and had greater mean FRAX scores (MOF: 15.9% vs. 10.1%) than participants without frailty. During follow-up, 38 participants with frailty (6.9%) and 91 without (3.0%) had MOFs. The AUC for FRAX (without BMD) was lower in participants with frailty (0.584; 95% CI 0.504-0.663) compared to those without (0.695; 95% CI 0.649-0.741); p value = 0.02. Among participants with frailty, the AUC improved when FRAX included BMD (AUC 0.658, p value < 0.01). FRAX overestimated MOF risk, with larger overestimations in individuals without frailty. Performance of FRAX for hip fracture was similar. CONCLUSION: FRAX may have been less able to identify frail individuals at risk for fracture, as compared with individuals without frailty, unless information on BMD is available. This suggests that BMD captures features important for fracture prediction in frail persons. Future fracture prediction models should be developed among persons with frailty.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Chattaris T, Yang L, Johansson H, et al. Performance of FRAX in older adults with frailty: the Framingham Heart Study. Osteoporos Int. 2023. PMID: 37872347. doi:10.1007/s00198-023-06950-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。